Seocalcitol
Alternative Names: CB-1089; EB-1089Latest Information Update: 20 Mar 2025
At a glance
- Originator LEO Pharma
- Developer Cougar Biotechnology; LEO Pharma
- Class Antineoplastics; Vitamin D analogues
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Liver cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 20 Mar 2025 Discontinued - Clinical-Phase-Unknown for Liver cancer (Late-stage disease) in Canada (PO)
- 20 Mar 2025 Discontinued - Clinical-Phase-Unknown for Liver cancer (Late-stage disease) in France (PO)
- 20 Mar 2025 Discontinued - Clinical-Phase-Unknown for Liver cancer (Late-stage disease) in Italy (PO)